Gonzmart Research Laboratory

Tampa, FL, United States

Gonzmart Research Laboratory

Tampa, FL, United States

Time filter

Source Type

Fu W.,Gonzmart Research Laboratory | Sharma S.S.,Gonzmart Research Laboratory | Ma L.,Gonzmart Research Laboratory | Chu B.,Gonzmart Research Laboratory | And 4 more authors.
Cell Death and Disease | Year: 2013

Osteosarcoma (OS) is an aggressive bone cancer typically observed in adolescents and young adults. Metastatic relapse accounts primarily for treatment failure, and obstacles to improving cure rates include a lack of efficacious agents. Our studies show apoptosis of OS cells prepared from localized and metastatic tumors by a novel drug combination: SCH727965 (SCH), a cyclin-dependent kinase inhibitor, and NVP-AUY922 (AUY) or other heat shock protein 90 inhibitor. SCH and AUY induced apoptosis when added simultaneously to cells and when AUY was added to and removed from cells before SCH addition. Sequential treatment was most effective when cells received AUY forB12 h and when SCH was presented to cells immediately after AUY removal. The apoptotic protein Bax accumulated in mitochondria of cotreated cells but was primarily cytosolic in cells receiving either agent alone. Additional data show that SCH and AUY cooperatively induce the apoptosis of other sarcoma cell types but not of normal osteoblasts or fibroblasts, and that SCH and AUY individually inhibit cell cycle progression throughout the cell cycle. We suggest that the combination of SCH and AUY may be an effective new strategy for treatment of OS. © 2013 Macmillan Publishers Limited.

Loading Gonzmart Research Laboratory collaborators
Loading Gonzmart Research Laboratory collaborators